drugset / Trial / NCT00539253
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
Completed
45 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bracco Diagnostics, Inc · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This research is being done to find out if using the contrast agent MultiHance can be used to show how a liver tumor responds to the chemotherapy given during Transcatheter Arterial Chemoembolization (TACE).
Timeline
- Start
- 2007-09
- Primary completion
- 2013-03
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadobenate dimeglumine | Diagnostic / imaging agent | — | — |